Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dundee researchers breakthrough in Cystic Fibrosis research

25.07.2006
`Fat controller’ offers key to breakthrough treatments in Cystic Fibrosis & other diseases

Researchers at the University of Dundee have uncovered key links between Cystic Fibrosis and other diseases and conditions including cancer, diabetes and obesity, findings which could open the pathway to new areas of research into understanding and treatment.

Dr Anil Mehta, who has worked in Cystic Fibrosis research for 20 years, and heads the European Union-funded Cystic Fibrosis Database based at the University, led the research which centres on the role in the body of a newly discovered hybrid protein dubbed the cellular “fat controller”.

Dr Mehta and his team have uncovered genetic pathways which lead through this fat controller and form links between Cystic Fibrosis and the other conditions.

“It has long been known that Cystic Fibrosis patients suffer significant variations in weight - they tend to be very thin and can suffer very fast weight loss when they fall ill - but we did not know why this was the case,” said Dr Mehta, a Reader in Child Health in the Department of Maternal and Child Health Sciences at the University of Dundee.

“Similarly it has been known that CF patients suffer a higher rate of cancer than normal and again we did not know why. In equal measure, almost half of these patients develop an unusual form of diabetes.

“What our research has uncovered are the genetic links, through this cellular fat controller, which we believe lead to these differences in fat metabolism and cancer. Furthermore, there are also significant links here to diabetes.”

Dr Mehta said the findings could have a major impact on research into Cystic Fibrosis and the other conditions and, subsequently, the treatment of patients..

“The implications of this are that we have opened up a whole new area of research which links all of these conditions, and from here on in researchers looking at cancer, diabetes, obesity or Cystic Fibrosis should all be working with each other and looking at what the other is doing, because it is all linked together.

“We believe that these results could have a significant impact in terms of the treatment of patients with all three diseases - Cystic Fibrosis, some forms of childhood cancer and adult onset diabetes - and, hence, their potential life expectancy.”

Dr Mehta’s research examined the relationship between three cancer-related enzymes that are associated with diabetes (NDPK), fat metabolism (AMPK) and Cystic Fibrosis (CFTR).

They found a new pathway between NDPK and AMPK which leads to variations in fat metabolism - this they have dubbed the fat controller. Additional research found that these enzymes also bind to a protein that causes cystic fibrosis, CFTR.

The new research work was carried out by Dr Mehta and a team including Research Fellow Dr Russell Crawford. A team of international collaborators in Italy, Germany, France Portugal and the USA provided further support.

Results of the research, funded by grants from the Wellcome Trust and Cystic Fibrosis Trust over the last 10 years, are published in the scientific journals ‘Cellular and Molecular Biology’ and ‘Cellular Signalling’.

In order to further debate and create greater cross-disciplinary collaboration in this area of research, the University has agreed to support Dr Mehta’s efforts to host a major international conference of experts in NDPK, AMPK and CFTR in Dundee in September 2007.

Roddy Isles | alfa
Further information:
http://www.dundee.ac.uk

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>